United States Biotechnology & Medical Research

Mineralys Therapeutics Inc (MLYS)

Track

Track

Mineralys Therapeutics experienced significant selling activity over the past ninety days, totaling over twelve million dollars. Multiple officers and directors executed planned divestments following a disappointing earnings report. These transactions reflect a negative net insider sentiment, occurring while the stock price remains near its annual low point.
Ticker: MLYS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mineralys Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
85.25
Quantity 8,347 +19.6%
Value US$2,180,267
3.5
Congleton Jon Officer; Director Executive Director
Transaction date
Proposed sale
Price
121.52
Quantity 89,965
Value US$4,012,314
3.5
Slingsby Brian Taylor Non-Executive Director
Transaction date
Sale
Price
309.10
Quantity 5,637 -30.3%
Value US$744,160
CATALYS PACIFIC FUND LP Director Non-Executive Director
Transaction date
Proposed sale
Price
28.81
Quantity 1,000
Value US$100,000
3.1
Warren Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
28.12
Quantity 1,000 -16.2%
Value US$100,000
3.1
Warren Eric Officer Officer
Transaction date
Proposed sale
Price
28.12
Quantity 1,000
Value US$100,000
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.95
Quantity 1,000
Value US$100,000
3.3
Karydas Daphne Non-Executive Director
Transaction date
Planned sale
Price
28.58
Quantity 1,000 -32.6%
Value US$100,000
3.3
Karydas Daphne Officer Officer
Transaction date
Proposed sale
Price
28.58
Quantity 1,000
Value US$100,000
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
28.14
Quantity 1,000
Value US$100,000
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
30.87
Quantity 2,171
Value US$67,019
3.1
Warren Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
25.98
Quantity 7,437 -16.2%
Value US$193,189
3.1
Warren Eric Officer Officer
Transaction date
Proposed sale
Price
25.98
Quantity 7,437
Value US$193,188
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
25.46
Quantity 417
Value US$10,617
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.48
Quantity 14,056
Value US$372,187
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.09
Quantity 2,170 -4.1%
Value US$58,785
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.09
Quantity 2,170
Value US$58,785
3.1
Warren Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
26.87
Quantity 7,438 -16.2%
Value US$199,885
3.1
Warren Eric Officer Officer
Transaction date
Proposed sale
Price
26.87
Quantity 7,438
Value US$199,885
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.53
Quantity 416 -0.8%
Value US$11,036
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.48
Quantity 416
Value US$11,016
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.61
Quantity 6,349 -11.0%
Value US$168,955
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.61
Quantity 6,349
Value US$168,955
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.24
Quantity 10,700 -1.7%
Value US$291,441
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.58
Quantity 14,058 -19.6%
Value US$387,717
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.58
Quantity 14,058
Value US$387,717
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.58
Quantity 14,058
Value US$387,717
3.5
Congleton Jon Officer; Director Executive Director
Transaction date
Proposed sale
Price
27.24
Quantity 10,700
Value US$291,441
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.72
Quantity 14,508
Value US$387,717
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.30
Quantity 2,171 -3.6%
Value US$65,781
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
30.30
Quantity 2,171
Value US$65,781
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.82
Quantity 17,000 -2.7%
Value US$455,896
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
25.94
Quantity 58,000 -8.4%
Value US$1,504,706
3.5
Congleton Jon Officer Officer
Transaction date
Proposed sale
Price
26.14
Quantity 75,000
Value US$1,960,602
3.1
Warren Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
25.90
Quantity 104,124 -73.1%
Value US$2,696,322
3.1
Warren Eric Officer Officer
Transaction date
Proposed sale
Price
25.90
Quantity 104,124
Value US$2,696,322
3.3
Karydas Daphne Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 3,000 -32.6%
Value US$75,000
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 4,584 -7.4%
Value US$114,600
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 4,584
Value US$114,600
3.3
Karydas Daphne Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 3,000
Value US$75,000
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
23.81
Quantity 9,890 -14.8%
Value US$235,487
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
23.81
Quantity 9,890
Value US$235,487
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
23.93
Quantity 6,349 -9.1%
Value US$151,901
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
23.93
Quantity 6,349
Value US$151,901
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
23.93
Quantity 6,349
Value US$151,901
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 2,170 -3.3%
Value US$54,250
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 2,170
Value US$54,250
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.55
Quantity 417 -0.7%
Value US$11,488
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.55
Quantity 417
Value US$11,488
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.55
Quantity 417
Value US$11,488
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.58
Quantity 14,056 -18.1%
Value US$401,789
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
28.58
Quantity 14,056
Value US$401,790
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.36
Quantity 6,348 -8.3%
Value US$186,348
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
29.36
Quantity 6,348
Value US$186,348
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.71
Quantity 2,171 -3.0%
Value US$64,500
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
29.71
Quantity 2,171
Value US$64,500
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
31.33
Quantity 416 -0.6%
Value US$13,033
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
31.33
Quantity 416
Value US$13,033
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.66
Quantity 6,348 -8.3%
Value US$175,586
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.66
Quantity 6,348
Value US$175,586
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
26.54
Quantity 14,058 -15.6%
Value US$373,087
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.83
Quantity 15,730 -2.2%
Value US$421,979
3.5
Congleton Jon Officer Officer
Transaction date
Proposed sale
Price
26.83
Quantity 15,730
Value US$421,980
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
26.54
Quantity 14,058
Value US$373,087
3.5
Rodman David Malcom Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.38
Quantity 2,170 -2.8%
Value US$59,415
3.5
Rodman David Malcom Officer Officer
Transaction date
Proposed sale
Price
27.38
Quantity 2,170
Value US$59,415
3.3
Karydas Daphne Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 3,000 -32.6%
Value US$75,000
3.3
Karydas Daphne Non-Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 3,000 -32.6%
Value US$75,000
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
27.05
Quantity 453 -0.1%
Value US$12,254
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
26.54
Quantity 55,183 -7.3%
Value US$1,464,474
3.5
Congleton Jon Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
25.50
Quantity 19,364 -2.5%
Value US$493,794
3.5
Congleton Jon Officer Officer
Transaction date
Proposed sale
Price
26.27
Quantity 75,000
Value US$1,970,521
3.3
Karydas Daphne Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 3,000
Value US$75,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-09-30 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
8,347 +19.6%
85.25
US$2,180,267 		8,347 +19.6% 85.25 US$2,180,267
2026-09-30 2026-09-30 PrS Proposed sale
3.5
Congleton Jon

Officer; Director

Executive Director
89,965
121.52
US$4,012,314 		89,965 121.52 US$4,012,314
2026-09-24 2026-09-22 S Sale
3.5
Slingsby Brian Taylor
Non-Executive Director
5,637 -30.3%
309.10
US$744,160 		5,637 -30.3% 309.10 US$744,160
2026-09-22 2026-09-22 PrS Proposed sale
CATALYS PACIFIC FUND LP

Director

Non-Executive Director
1,000
28.81
US$100,000 		1,000 28.81 US$100,000
2026-09-22 2026-09-21 PlS Planned sale
3.1
Warren Eric

Chief Commercial Officer

Officer
1,000 -16.2%
28.12
US$100,000 		1,000 -16.2% 28.12 US$100,000
2026-09-21 2026-09-21 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
1,000
28.12
US$100,000 		1,000 28.12 US$100,000
2026-09-17 2026-09-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
1,000
27.95
US$100,000 		1,000 27.95 US$100,000
2026-09-17 2026-09-15 PlS Planned sale
3.3
Karydas Daphne
Non-Executive Director
1,000 -32.6%
28.58
US$100,000 		1,000 -32.6% 28.58 US$100,000
2026-09-15 2026-09-15 PrS Proposed sale
3.3
Karydas Daphne

Officer

Officer
1,000
28.58
US$100,000 		1,000 28.58 US$100,000
2026-09-14 2026-09-14 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
1,000
28.14
US$100,000 		1,000 28.14 US$100,000
2026-09-09 2026-09-09 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,171
30.87
US$67,019 		2,171 30.87 US$67,019
2026-08-25 2026-08-21 PlS Planned sale
3.1
Warren Eric

Chief Commercial Officer

Officer
7,437 -16.2%
25.98
US$193,189 		7,437 -16.2% 25.98 US$193,189
2026-08-21 2026-08-21 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
7,437
25.98
US$193,188 		7,437 25.98 US$193,188
2026-08-17 2026-08-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
417
25.46
US$10,617 		417 25.46 US$10,617
2026-08-13 2026-08-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,056
26.48
US$372,187 		14,056 26.48 US$372,187
2026-08-12 2026-08-10 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,170 -4.1%
27.09
US$58,785 		2,170 -4.1% 27.09 US$58,785
2026-08-10 2026-08-10 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,170
27.09
US$58,785 		2,170 27.09 US$58,785
2026-07-23 2026-07-21 PlS Planned sale
3.1
Warren Eric

Chief Commercial Officer

Officer
7,438 -16.2%
26.87
US$199,885 		7,438 -16.2% 26.87 US$199,885
2026-07-21 2026-07-21 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
7,438
26.87
US$199,885 		7,438 26.87 US$199,885
2026-07-20 2026-07-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
416 -0.8%
26.53
US$11,036 		416 -0.8% 26.53 US$11,036
2026-07-17 2026-07-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
416
26.48
US$11,016 		416 26.48 US$11,016
2026-07-15 2026-07-15 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,349 -11.0%
26.61
US$168,955 		6,349 -11.0% 26.61 US$168,955
2026-07-15 2026-07-15 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,349
26.61
US$168,955 		6,349 26.61 US$168,955
2026-07-15 2026-07-13 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
10,700 -1.7%
27.24
US$291,441 		10,700 -1.7% 27.24 US$291,441
2026-07-15 2026-07-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
14,058 -19.6%
27.58
US$387,717 		14,058 -19.6% 27.58 US$387,717
2026-07-14 2026-07-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,058
27.58
US$387,717 		14,058 27.58 US$387,717
2026-07-14 2026-07-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,058
27.58
US$387,717 		14,058 27.58 US$387,717
2026-07-13 2026-07-13 PrS Proposed sale
3.5
Congleton Jon

Officer; Director

Executive Director
10,700
27.24
US$291,441 		10,700 27.24 US$291,441
2026-07-13 2026-07-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,508
26.72
US$387,717 		14,508 26.72 US$387,717
2026-07-10 2026-07-09 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,171 -3.6%
30.30
US$65,781 		2,171 -3.6% 30.30 US$65,781
2026-07-09 2026-07-09 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,171
30.30
US$65,781 		2,171 30.30 US$65,781
2026-06-30 2026-06-30 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
17,000 -2.7%
26.82
US$455,896 		17,000 -2.7% 26.82 US$455,896
2026-06-30 2026-06-30 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
58,000 -8.4%
25.94
US$1,504,706 		58,000 -8.4% 25.94 US$1,504,706
2026-06-30 2026-06-30 PrS Proposed sale
3.5
Congleton Jon

Officer

Officer
75,000
26.14
US$1,960,602 		75,000 26.14 US$1,960,602
2026-06-30 2026-06-26 PlS Planned sale
3.1
Warren Eric

Chief Commercial Officer

Officer
104,124 -73.1%
25.90
US$2,696,322 		104,124 -73.1% 25.90 US$2,696,322
2026-06-29 2026-06-26 PrS Proposed sale
3.1
Warren Eric

Officer

Officer
104,124
25.90
US$2,696,322 		104,124 25.90 US$2,696,322
2026-06-17 2026-06-17 PlS Planned sale
3.3
Karydas Daphne
Non-Executive Director
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-06-17 2026-06-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
4,584 -7.4%
25.00
US$114,600 		4,584 -7.4% 25.00 US$114,600
2026-06-17 2026-06-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
4,584
25.00
US$114,600 		4,584 25.00 US$114,600
2026-06-17 2026-06-17 PrS Proposed sale
3.3
Karydas Daphne

Officer

Officer
3,000
25.00
US$75,000 		3,000 25.00 US$75,000
2026-06-17 2026-06-15 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
9,890 -14.8%
23.81
US$235,487 		9,890 -14.8% 23.81 US$235,487
2026-06-15 2026-06-15 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
9,890
23.81
US$235,487 		9,890 23.81 US$235,487
2026-06-12 2026-06-12 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,349 -9.1%
23.93
US$151,901 		6,349 -9.1% 23.93 US$151,901
2026-06-12 2026-06-12 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,349
23.93
US$151,901 		6,349 23.93 US$151,901
2026-06-12 2026-06-12 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,349
23.93
US$151,901 		6,349 23.93 US$151,901
2026-06-12 2026-06-10 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,170 -3.3%
25.00
US$54,250 		2,170 -3.3% 25.00 US$54,250
2026-06-10 2026-06-10 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,170
25.00
US$54,250 		2,170 25.00 US$54,250
2026-05-19 2026-05-18 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
417 -0.7%
27.55
US$11,488 		417 -0.7% 27.55 US$11,488
2026-05-18 2026-05-18 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
417
27.55
US$11,488 		417 27.55 US$11,488
2026-05-18 2026-05-18 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
417
27.55
US$11,488 		417 27.55 US$11,488
2026-05-13 2026-05-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
14,056 -18.1%
28.58
US$401,789 		14,056 -18.1% 28.58 US$401,789
2026-05-13 2026-05-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,056
28.58
US$401,790 		14,056 28.58 US$401,790
2026-05-13 2026-05-12 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,348 -8.3%
29.36
US$186,348 		6,348 -8.3% 29.36 US$186,348
2026-05-12 2026-05-12 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,348
29.36
US$186,348 		6,348 29.36 US$186,348
2026-05-13 2026-05-11 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,171 -3.0%
29.71
US$64,500 		2,171 -3.0% 29.71 US$64,500
2026-05-11 2026-05-11 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,171
29.71
US$64,500 		2,171 29.71 US$64,500
2026-04-21 2026-04-17 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
416 -0.6%
31.33
US$13,033 		416 -0.6% 31.33 US$13,033
2026-04-17 2026-04-17 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
416
31.33
US$13,033 		416 31.33 US$13,033
2026-04-15 2026-04-15 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
6,348 -8.3%
27.66
US$175,586 		6,348 -8.3% 27.66 US$175,586
2026-04-15 2026-04-15 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
6,348
27.66
US$175,586 		6,348 27.66 US$175,586
2026-04-15 2026-04-13 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
14,058 -15.6%
26.54
US$373,087 		14,058 -15.6% 26.54 US$373,087
2026-04-15 2026-04-13 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
15,730 -2.2%
26.83
US$421,979 		15,730 -2.2% 26.83 US$421,979
2026-04-13 2026-04-13 PrS Proposed sale
3.5
Congleton Jon

Officer

Officer
15,730
26.83
US$421,980 		15,730 26.83 US$421,980
2026-04-13 2026-04-13 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
14,058
26.54
US$373,087 		14,058 26.54 US$373,087
2026-04-13 2026-04-09 PlS Planned sale
3.5
Rodman David Malcom

Chief Medical Officer

Officer
2,170 -2.8%
27.38
US$59,415 		2,170 -2.8% 27.38 US$59,415
2026-04-09 2026-04-09 PrS Proposed sale
3.5
Rodman David Malcom

Officer

Officer
2,170
27.38
US$59,415 		2,170 27.38 US$59,415
2026-04-02 2026-03-31 PlS Planned sale
3.3
Karydas Daphne
Non-Executive Director
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-04-02 2026-03-31 PlS Planned sale
3.3
Karydas Daphne
Non-Executive Director
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-04-02 2026-03-31 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
453 -0.1%
27.05
US$12,254 		453 -0.1% 27.05 US$12,254
2026-04-02 2026-03-31 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
55,183 -7.3%
26.54
US$1,464,474 		55,183 -7.3% 26.54 US$1,464,474
2026-04-02 2026-03-31 PlS Planned sale
3.5
Congleton Jon

Chief Executive Officer

Executive Director
19,364 -2.5%
25.50
US$493,794 		19,364 -2.5% 25.50 US$493,794
2026-03-31 2026-03-31 PrS Proposed sale
3.5
Congleton Jon

Officer

Officer
75,000
26.27
US$1,970,521 		75,000 26.27 US$1,970,521
2026-03-31 2026-03-31 PrS Proposed sale
3.3
Karydas Daphne

Officer

Officer
3,000
25.00
US$75,000 		3,000 25.00 US$75,000
2026-03-31 2026-03-30 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
58,300 +1.0%
24.16
US$1,408,528 		58,300 +1.0% 24.16 US$1,408,528
2026-03-31 2026-03-27 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director
310,700 +5.7%
23.67
US$7,354,269 		310,700 +5.7% 23.67 US$7,354,269
Explore more

More insider trading research around Mineralys Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America